Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 31

Trial Status

Completed3
Terminated3

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT05261711Phase 1/2Terminated
AB1 in Adult Patients With Sickle Cell Disease (SCD)
Sickle Cell Disease
PrincipalinvestigatorStart date: 2022-12-05
NCT03387033Not ApplicableTerminated
Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)
AnxietyCancerDepression+2 more
PrincipalinvestigatorStart date: 2018-02-05
NCT01833702Completed
Use of a Mobile-based App for SCD Patients
Chronic PainSickle Cell Disease
PrincipalinvestigatorStart date: 2012-06-01
NCT02133560Not ApplicableCompleted
Use of Mobile Technology for Intensive Training in Medication Management
Sickle Cell DiseaseThalassemia
Principalinvestigator
NCT02179177Phase 3Terminated
Apixaban in Patients With Sickle Cell Disease
Reduction in HospitalizationsSickle Cell DiseaseVaso-occlusive Crisis
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT05261711Phase 1/2PrincipalInvestigator

AB1 in Adult Patients With Sickle Cell Disease (SCD)

Sickle Cell Disease
Terminated
NCT03387033Not ApplicablePrincipalInvestigator

Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)

AnxietyCancerDepression+2 more
Terminated
NCT01833702PrincipalInvestigator

Use of a Mobile-based App for SCD Patients

Chronic PainSickle Cell Disease
Completed
NCT01419977Phase 2PrincipalInvestigator

Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo

Sickle Cell DiseaseVaso-occlusive Crisis
Completed
NCT02133560Not ApplicablePrincipalInvestigator

Use of Mobile Technology for Intensive Training in Medication Management

Sickle Cell DiseaseThalassemia
Completed
NCT02179177Phase 3PrincipalInvestigator

Apixaban in Patients With Sickle Cell Disease

Reduction in HospitalizationsSickle Cell DiseaseVaso-occlusive Crisis
Terminated

All 6 trials loaded